Selected research
Market Outlook & Growth Opportunities
Global AI Clinical Decision Support Software Market Outlook and Growth Opportunities 2026
Market perspective
The global AI Clinical Decision Support Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AI Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AI Clinical Decision Support Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AI Clinical Decision Support Software market include Philips N.V., Siemens Healthineers AG, GE HealthCare Technologies Inc., Aidoc Medical Ltd., Viz.ai, Inc., Tempus AI, Inc., Flatiron Health, Inc., Dedalus S.p.A. and Fujitsu Limited, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AI Clinical Decision Support Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Clinical Decision Support Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Clinical Decision Support Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Clinical Decision Support Software market.
AI Clinical Decision Support Software Segment by Company
Philips N.V.
Siemens Healthineers AG
GE HealthCare Technologies Inc.
Aidoc Medical Ltd.
Viz.ai, Inc.
Tempus AI, Inc.
Flatiron Health, Inc.
Dedalus S.p.A.
Fujitsu Limited
Yidu Tech Inc.
Winning Health Technology Group Co., Ltd.
Epic Systems Corporation
Wolters Kluwer N.V.
Elsevier B.V.
AI Clinical Decision Support Software Segment by Type
AI-Assisted Diagnostic Decision Support Software
AI Treatment Plan Recommendation Software
AI Medication Decision Support Software
AI Disease Risk Prediction Software
Others
AI Clinical Decision Support Software Segment by Application
Oncology
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Chronic Disease Management
Others
AI Clinical Decision Support Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AI Clinical Decision Support Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AI Clinical Decision Support Software key companies, revenue, market share, and recent developments.
3. To split the AI Clinical Decision Support Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AI Clinical Decision Support Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AI Clinical Decision Support Software significant trends, drivers, influence factors in global and regions.
6. To analyze AI Clinical Decision Support Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Decision Support Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Decision Support Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Decision Support Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Decision Support Software industry.
Chapter 3: Detailed analysis of AI Clinical Decision Support Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AI Clinical Decision Support Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AI Clinical Decision Support Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- AI-Assisted Diagnostic Decision Support Software
- AI Treatment Plan Recommendation Software
- AI Medication Decision Support Software
- AI Disease Risk Prediction Software
- Others
Applications
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Chronic Disease Management
- Others
Companies covered
- Philips N.V.
- Siemens Healthineers AG
- GE HealthCare Technologies Inc.
- Aidoc Medical Ltd.
- Viz.ai, Inc.
- Tempus AI, Inc.
- Flatiron Health, Inc.
- Dedalus S.p.A.
- Fujitsu Limited
- Yidu Tech Inc.
- Winning Health Technology Group Co., Ltd.
- Epic Systems Corporation
- Wolters Kluwer N.V.
- Elsevier B.V.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AI Clinical Decision Support Software Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AI Clinical Decision Support Software Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Clinical Decision Support Software Market Dynamics
- 2.1 AI Clinical Decision Support Software Industry Trends
- 2.2 AI Clinical Decision Support Software Industry Drivers
- 2.3 AI Clinical Decision Support Software Industry Opportunities and Challenges
- 2.4 AI Clinical Decision Support Software Industry Restraints
3 AI Clinical Decision Support Software Market by Company
- 3.1 Global AI Clinical Decision Support Software Company Revenue Ranking in 2025
- 3.2 Global AI Clinical Decision Support Software Revenue by Company (2021-2026)
- 3.3 Global AI Clinical Decision Support Software Company Ranking (2024-2026)
- 3.4 Global AI Clinical Decision Support Software Company Manufacturing Base and Headquarters
- 3.5 Global AI Clinical Decision Support Software Company Product Type and Application
- 3.6 Global AI Clinical Decision Support Software Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AI Clinical Decision Support Software Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AI Clinical Decision Support Software Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AI Clinical Decision Support Software Market by Type
- 4.1 AI Clinical Decision Support Software Type Introduction
- 4.1.1 AI-Assisted Diagnostic Decision Support Software
- 4.1.2 AI Treatment Plan Recommendation Software
- 4.1.3 AI Medication Decision Support Software
- 4.1.4 AI Disease Risk Prediction Software
- 4.1.5 Others
- 4.2 Global AI Clinical Decision Support Software Sales Value by Type
- 4.2.1 Global AI Clinical Decision Support Software Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AI Clinical Decision Support Software Sales Value by Type (2021-2032)
- 4.2.3 Global AI Clinical Decision Support Software Sales Value Share by Type (2021-2032)
5 AI Clinical Decision Support Software Market by Application
- 5.1 AI Clinical Decision Support Software Application Introduction
- 5.1.1 Oncology
- 5.1.2 Cardiovascular Diseases
- 5.1.3 Neurological Disorders
- 5.1.4 Infectious Diseases
- 5.1.5 Chronic Disease Management
- 5.1.6 Others
- 5.2 Global AI Clinical Decision Support Software Sales Value by Application
- 5.2.1 Global AI Clinical Decision Support Software Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AI Clinical Decision Support Software Sales Value by Application (2021-2032)
- 5.2.3 Global AI Clinical Decision Support Software Sales Value Share by Application (2021-2032)
6 AI Clinical Decision Support Software Regional Value Analysis
- 6.1 Global AI Clinical Decision Support Software Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AI Clinical Decision Support Software Sales Value by Region (2021-2032)
- 6.2.1 Global AI Clinical Decision Support Software Sales Value by Region: 2021-2026
- 6.2.2 Global AI Clinical Decision Support Software Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AI Clinical Decision Support Software Sales Value (2021-2032)
- 6.3.2 North America AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AI Clinical Decision Support Software Sales Value (2021-2032)
- 6.4.2 Europe AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AI Clinical Decision Support Software Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AI Clinical Decision Support Software Sales Value (2021-2032)
- 6.6.2 South America AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AI Clinical Decision Support Software Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
7 AI Clinical Decision Support Software Country-level Value Analysis
- 7.1 Global AI Clinical Decision Support Software Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AI Clinical Decision Support Software Sales Value by Country (2021-2032)
- 7.2.1 Global AI Clinical Decision Support Software Sales Value by Country (2021-2026)
- 7.2.2 Global AI Clinical Decision Support Software Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.7.2 France AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.14.2 China AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.17.2 India AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Philips N.V.
- 8.1.1 Philips N.V. Company Information
- 8.1.2 Philips N.V. Business Overview
- 8.1.3 Philips N.V. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.1.4 Philips N.V. AI Clinical Decision Support Software Product Portfolio
- 8.1.5 Philips N.V. Recent Developments
- 8.2 Siemens Healthineers AG
- 8.2.1 Siemens Healthineers AG Company Information
- 8.2.2 Siemens Healthineers AG Business Overview
- 8.2.3 Siemens Healthineers AG AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.2.4 Siemens Healthineers AG AI Clinical Decision Support Software Product Portfolio
- 8.2.5 Siemens Healthineers AG Recent Developments
- 8.3 GE HealthCare Technologies Inc.
- 8.3.1 GE HealthCare Technologies Inc. Company Information
- 8.3.2 GE HealthCare Technologies Inc. Business Overview
- 8.3.3 GE HealthCare Technologies Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.3.4 GE HealthCare Technologies Inc. AI Clinical Decision Support Software Product Portfolio
- 8.3.5 GE HealthCare Technologies Inc. Recent Developments
- 8.4 Aidoc Medical Ltd.
- 8.4.1 Aidoc Medical Ltd. Company Information
- 8.4.2 Aidoc Medical Ltd. Business Overview
- 8.4.3 Aidoc Medical Ltd. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.4.4 Aidoc Medical Ltd. AI Clinical Decision Support Software Product Portfolio
- 8.4.5 Aidoc Medical Ltd. Recent Developments
- 8.5 Viz.ai, Inc.
- 8.5.1 Viz.ai, Inc. Company Information
- 8.5.2 Viz.ai, Inc. Business Overview
- 8.5.3 Viz.ai, Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.5.4 Viz.ai, Inc. AI Clinical Decision Support Software Product Portfolio
- 8.5.5 Viz.ai, Inc. Recent Developments
- 8.6 Tempus AI, Inc.
- 8.6.1 Tempus AI, Inc. Company Information
- 8.6.2 Tempus AI, Inc. Business Overview
- 8.6.3 Tempus AI, Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.6.4 Tempus AI, Inc. AI Clinical Decision Support Software Product Portfolio
- 8.6.5 Tempus AI, Inc. Recent Developments
- 8.7 Flatiron Health, Inc.
- 8.7.1 Flatiron Health, Inc. Company Information
- 8.7.2 Flatiron Health, Inc. Business Overview
- 8.7.3 Flatiron Health, Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.7.4 Flatiron Health, Inc. AI Clinical Decision Support Software Product Portfolio
- 8.7.5 Flatiron Health, Inc. Recent Developments
- 8.8 Dedalus S.p.A.
- 8.8.1 Dedalus S.p.A. Company Information
- 8.8.2 Dedalus S.p.A. Business Overview
- 8.8.3 Dedalus S.p.A. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.8.4 Dedalus S.p.A. AI Clinical Decision Support Software Product Portfolio
- 8.8.5 Dedalus S.p.A. Recent Developments
- 8.9 Fujitsu Limited
- 8.9.1 Fujitsu Limited Company Information
- 8.9.2 Fujitsu Limited Business Overview
- 8.9.3 Fujitsu Limited AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.9.4 Fujitsu Limited AI Clinical Decision Support Software Product Portfolio
- 8.9.5 Fujitsu Limited Recent Developments
- 8.10 Yidu Tech Inc.
- 8.10.1 Yidu Tech Inc. Company Information
- 8.10.2 Yidu Tech Inc. Business Overview
- 8.10.3 Yidu Tech Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.10.4 Yidu Tech Inc. AI Clinical Decision Support Software Product Portfolio
- 8.10.5 Yidu Tech Inc. Recent Developments
- 8.11 Winning Health Technology Group Co., Ltd.
- 8.11.1 Winning Health Technology Group Co., Ltd. Company Information
- 8.11.2 Winning Health Technology Group Co., Ltd. Business Overview
- 8.11.3 Winning Health Technology Group Co., Ltd. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.11.4 Winning Health Technology Group Co., Ltd. AI Clinical Decision Support Software Product Portfolio
- 8.11.5 Winning Health Technology Group Co., Ltd. Recent Developments
- 8.12 Epic Systems Corporation
- 8.12.1 Epic Systems Corporation Company Information
- 8.12.2 Epic Systems Corporation Business Overview
- 8.12.3 Epic Systems Corporation AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.12.4 Epic Systems Corporation AI Clinical Decision Support Software Product Portfolio
- 8.12.5 Epic Systems Corporation Recent Developments
- 8.13 Wolters Kluwer N.V.
- 8.13.1 Wolters Kluwer N.V. Company Information
- 8.13.2 Wolters Kluwer N.V. Business Overview
- 8.13.3 Wolters Kluwer N.V. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.13.4 Wolters Kluwer N.V. AI Clinical Decision Support Software Product Portfolio
- 8.13.5 Wolters Kluwer N.V. Recent Developments
- 8.14 Elsevier B.V.
- 8.14.1 Elsevier B.V. Company Information
- 8.14.2 Elsevier B.V. Business Overview
- 8.14.3 Elsevier B.V. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
- 8.14.4 Elsevier B.V. AI Clinical Decision Support Software Product Portfolio
- 8.14.5 Elsevier B.V. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst